Youngevity International (NASDAQ:YGYI) Announces Earnings Results

Youngevity International (NASDAQ:YGYI) issued its quarterly earnings results on Wednesday. The company reported ($0.02) earnings per share (EPS) for the quarter, Morningstar.com reports. The business had revenue of $53.69 million for the quarter. Youngevity International had a negative return on equity of 125.30% and a negative net margin of 17.08%.

NASDAQ:YGYI traded down $0.25 on Thursday, reaching $4.68. 405 shares of the company’s stock were exchanged, compared to its average volume of 74,472. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.16 and a quick ratio of 0.49. The business has a fifty day simple moving average of $5.21. Youngevity International has a 52-week low of $3.57 and a 52-week high of $16.25.

Separately, ValuEngine lowered shares of Youngevity International from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st.



In other Youngevity International news, Director Paul Sallwasser sold 5,140 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $5.04, for a total transaction of $25,905.60. Following the sale, the director now directly owns 62,853 shares in the company, valued at $316,779.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 55.60% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in YGYI. BlackRock Inc. grew its position in shares of Youngevity International by 2,064.8% during the second quarter. BlackRock Inc. now owns 514,737 shares of the company’s stock worth $2,934,000 after buying an additional 490,959 shares in the last quarter. 1492 Capital Management LLC grew its position in shares of Youngevity International by 347.8% during the second quarter. 1492 Capital Management LLC now owns 107,313 shares of the company’s stock worth $612,000 after buying an additional 83,348 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Youngevity International by 18.5% during the second quarter. Vanguard Group Inc. now owns 474,118 shares of the company’s stock worth $2,702,000 after buying an additional 74,183 shares in the last quarter. Granite Investment Partners LLC grew its position in shares of Youngevity International by 87.7% during the first quarter. Granite Investment Partners LLC now owns 108,433 shares of the company’s stock worth $618,000 after buying an additional 50,679 shares in the last quarter. Finally, Geode Capital Management LLC acquired a new position in shares of Youngevity International during the fourth quarter worth about $256,000. 4.88% of the stock is owned by institutional investors and hedge funds.

About Youngevity International

Youngevity International, Inc develops and distributes health and nutrition related products and services through independent direct selling network in the United States and internationally. It operates in two segments, Direct Selling and Commercial Coffee. The company offers approximately 5,500 products, including nutritional, vitamin, mineral, herbal, liquid, and dietary supplements; apparel; fashion and jewelry accessories; digital products; and packaged foods.

Featured Article: P/E Growth (PEG)

Earnings History for Youngevity International (NASDAQ:YGYI)

Receive News & Ratings for Youngevity International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Youngevity International and related companies with MarketBeat.com's FREE daily email newsletter.